Back to Results
First PageMeta Content
Chemistry / Sulfones / Vismodegib / Basal-cell carcinoma / End point of clinical trials / Medicine / Oncology / Organochlorides


Long-Term Safety and Efficacy of Vismodegib in Patients With Advanced Basal Cell Carcinoma (aBCC): 18-Month Update of the Pivotal ERIVANCE BCC Study Aleksandar Sekulic,1 Michael R. Migden,2 Nicole Basset-Seguin,3 Claus G
Add to Reading List

Document Date: 2014-05-12 19:51:30

Open Document

File Size: 582,81 KB

Share Result on Facebook

City

South San Francisco / Ann Arbor / Rochester / Würzburg / Houston / Tübingen / Paris / Scottsdale / Los Angeles / Essen / Lille / Chicago / /

Company

AEs / The vismodegib AE / Blyth / OBJECTIVES Oncology Group / Curis Inc. / Genentech / 12Genentech Inc. / F. Hoffmann-La Roche Ltd. / Chugai Pharmaceuticals / Oro AE / Metastatic Locally / /

Continent

Europe / /

Country

Germany / France / Japan / United States / Australia / Korea / /

/

Event

Business Partnership / /

Facility

Angeles Clinic / University of New South Wales / Research Institute / Clinic Rochester / Jorge F. Quevedo / 11 Jeannie Hou / 12 Howard M. Mackey / 12 Dirk Schadendorf13 Mayo Clinic / University of Pennsylvania / Texas MD Anderson Cancer Center / /

IndustryTerm

magnetic resonance imaging / /

MedicalCondition

Significant morbidity/deformity / basal cell carcinoma / mg/day Until disease / Headache / archival tumor / Muscle spasms / Nausea / alopecia / muscle spasm / Fatigue / deformity / Substantial deformity / Diarrhea / Ageusia / Constipation / advanced basal cell carcinoma laBCC / tumor / Squamous cell carcinoma / measurable disease / Cancer / disease / Arthralgia / Nasopharyngitis / nodal metastases / dysgeusia / Hypogeusia / Progressive disease / Vomiting / Response Evaluation Criteria In Solid Tumors / Stable disease / Leverkus M. J Skin Cancer / Cough / Patients With Advanced Basal Cell Carcinoma / /

MedicalTreatment

radiotherapy / surgery / radiation / /

MusicGroup

Nausea / /

Organization

the University of Pennsylvania / Philadelphia / American Society of Clinical Oncology / 10The Angeles Clinic and Research Institute / University of New South Wales / Sydney / US Food and Drug Administration / FDA / /

Person

Aleksandar Sekulic / /

Position

investigator / driver / LoRusso PM / independent pathologist / Corresponding author / author / Discontinued treatment Physician / treatment pathologist / /

ProvinceOrState

Texas / Michigan / Pennsylvania / New South Wales / Arizona / /

Region

South Wales / /

Technology

radiation / tomography / magnetic resonance imaging / /

URL

http /

SocialTag